View source for Your miR3613p improves enzalutamide Enz sensitivity by means of targeting the ARv7 and MKNK2 to raised reduce the actual Enzresistant prostate cancer
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.